Bionano Genomics, Inc.
BNGO
$4.08
-$0.02-0.49%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -81.20% | -75.42% | -70.44% | -41.01% | -64.71% |
| Total Receivables | -40.73% | -20.69% | 25.56% | 28.88% | 53.87% |
| Inventory | -45.81% | -39.99% | -40.85% | -23.08% | 5.52% |
| Prepaid Expenses | -21.05% | -5.11% | -30.79% | -20.62% | -22.08% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 625.91% | -- |
| Total Current Assets | -55.06% | -50.59% | -39.95% | -10.92% | -52.09% |
|
|
|||||
| Total Current Assets | -55.06% | -50.59% | -39.95% | -10.92% | -52.09% |
| Net Property, Plant & Equipment | -15.53% | 6.28% | 12.88% | 12.17% | 20.83% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -69.12% | -20.07% | -19.36% | -17.42% | 58.36% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -70.24% | 84.97% | 121.29% | 178.29% | 1,222.94% |
| Total Assets | -51.97% | -52.33% | -45.92% | -30.28% | -43.80% |
|
|
|||||
| Total Accounts Payable | -43.39% | -26.68% | -37.62% | -17.15% | 63.38% |
| Total Accrued Expenses | -55.03% | -43.74% | -24.76% | -28.62% | 15.94% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -9.87% | 4.88% | -2.30% | -4.32% | 18.82% |
| Total Finance Division Other Current Liabilities | -79.59% | -77.07% | -6.52% | -6.56% | -8.08% |
| Total Other Current Liabilities | -79.59% | -77.07% | -6.52% | -6.56% | -8.08% |
| Total Current Liabilities | -18.02% | 10.97% | 53.42% | 178.75% | 19.98% |
|
|
|||||
| Total Current Liabilities | -18.02% | 10.97% | 53.42% | 178.75% | 19.98% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -31.24% | -30.63% | -26.86% | -21.35% | -7.69% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -98.25% | -59.03% | -25.13% | -15.68% | 10,952.21% |
| Total Liabilities | -38.81% | -13.42% | 24.00% | 103.51% | 49.93% |
|
|
|||||
| Common Stock & APIC | 9.75% | 10.84% | 12.53% | 13.03% | 10.58% |
| Retained Earnings | -25.27% | -48.05% | -58.78% | -66.67% | -73.31% |
| Treasury Stock & Other | 1,749.46% | 99.03% | 97.59% | 102.05% | 94.90% |
| Total Common Equity | -58.93% | -62.59% | -64.24% | -61.44% | -57.76% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -58.93% | -62.59% | -64.24% | -61.44% | -57.76% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -58.93% | -62.59% | -64.24% | -61.44% | -57.76% |
|
|
|||||
